G. V R K Sharma, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 37 | 2009 | 2600 | 0.770 |
Why?
|
| Vascular Surgical Procedures | 4 | 2017 | 1515 | 0.710 |
Why?
|
| Adiponectin | 2 | 2016 | 1117 | 0.670 |
Why?
|
| Ventricular Pressure | 2 | 2011 | 210 | 0.550 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2016 | 200 | 0.510 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2017 | 216 | 0.500 |
Why?
|
| Hernia | 1 | 2015 | 68 | 0.480 |
Why?
|
| Spinal Cord Injuries | 5 | 2009 | 929 | 0.460 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2014 | 96 | 0.450 |
Why?
|
| Gallbladder Diseases | 1 | 2015 | 139 | 0.450 |
Why?
|
| Aneurysm, Infected | 1 | 2014 | 81 | 0.440 |
Why?
|
| Anatomy | 1 | 2015 | 126 | 0.440 |
Why?
|
| Cadaver | 1 | 2015 | 1366 | 0.370 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 937 | 0.360 |
Why?
|
| Surgical Wound Infection | 2 | 2017 | 1547 | 0.340 |
Why?
|
| Bundle-Branch Block | 2 | 2009 | 278 | 0.340 |
Why?
|
| Streptococcal Infections | 1 | 2014 | 619 | 0.330 |
Why?
|
| Endarterectomy, Carotid | 1 | 2015 | 557 | 0.330 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2014 | 530 | 0.330 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2011 | 252 | 0.330 |
Why?
|
| Aneurysm, Ruptured | 1 | 2014 | 462 | 0.320 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 954 | 0.300 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1769 | 0.300 |
Why?
|
| Peripheral Arterial Disease | 2 | 2017 | 1304 | 0.290 |
Why?
|
| Carotid Stenosis | 1 | 2015 | 862 | 0.290 |
Why?
|
| General Surgery | 2 | 2017 | 1722 | 0.290 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 2059 | 0.260 |
Why?
|
| Coronary Artery Bypass | 10 | 2006 | 2194 | 0.260 |
Why?
|
| Urokinase-Type Plasminogen Activator | 11 | 2000 | 324 | 0.250 |
Why?
|
| Streptokinase | 9 | 2000 | 186 | 0.250 |
Why?
|
| Cheyne-Stokes Respiration | 1 | 2005 | 38 | 0.250 |
Why?
|
| Ventricular Function, Left | 3 | 2011 | 3941 | 0.250 |
Why?
|
| Patient Care Team | 1 | 2016 | 2528 | 0.240 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 2008 | 0.240 |
Why?
|
| Patient Discharge | 2 | 2016 | 3491 | 0.230 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 1756 | 0.220 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 2909 | 0.220 |
Why?
|
| Fibrinolytic Agents | 13 | 2000 | 2080 | 0.210 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2002 | 276 | 0.200 |
Why?
|
| Length of Stay | 1 | 2016 | 6526 | 0.200 |
Why?
|
| Patient Readmission | 2 | 2016 | 3313 | 0.190 |
Why?
|
| Pancreatic Neoplasms | 2 | 2017 | 5443 | 0.180 |
Why?
|
| Melanoma | 2 | 2016 | 5709 | 0.180 |
Why?
|
| Models, Statistical | 1 | 2015 | 5110 | 0.180 |
Why?
|
| Angina, Unstable | 4 | 1993 | 893 | 0.170 |
Why?
|
| Heparin | 15 | 2000 | 1636 | 0.170 |
Why?
|
| Clinical Competence | 1 | 2015 | 4860 | 0.170 |
Why?
|
| Blood Pressure Determination | 1 | 2002 | 646 | 0.160 |
Why?
|
| Respiration | 1 | 2005 | 1668 | 0.150 |
Why?
|
| Lower Extremity | 2 | 2017 | 1217 | 0.150 |
Why?
|
| Stroke Volume | 3 | 2011 | 5622 | 0.150 |
Why?
|
| Seroma | 1 | 2017 | 74 | 0.140 |
Why?
|
| Tissue Plasminogen Activator | 6 | 1992 | 1165 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 5864 | 0.140 |
Why?
|
| Cholecystography | 1 | 2015 | 42 | 0.130 |
Why?
|
| Hemodynamics | 7 | 2000 | 4199 | 0.120 |
Why?
|
| Neurofibromin 1 | 1 | 2016 | 190 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 9213 | 0.120 |
Why?
|
| Facial Transplantation | 1 | 2017 | 222 | 0.120 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2017 | 373 | 0.110 |
Why?
|
| Biopsy | 2 | 2016 | 6805 | 0.110 |
Why?
|
| Organizational Innovation | 1 | 2017 | 540 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2015 | 278 | 0.110 |
Why?
|
| Coronary Disease | 5 | 2002 | 5919 | 0.110 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2017 | 516 | 0.110 |
Why?
|
| Blood Pressure | 5 | 2005 | 8544 | 0.100 |
Why?
|
| Stroke | 1 | 2015 | 9756 | 0.100 |
Why?
|
| Hirudins | 1 | 1993 | 179 | 0.100 |
Why?
|
| Male | 31 | 2017 | 365203 | 0.100 |
Why?
|
| Postoperative Care | 3 | 2016 | 1481 | 0.100 |
Why?
|
| Middle Aged | 29 | 2017 | 223737 | 0.100 |
Why?
|
| Isoproterenol | 1 | 1992 | 398 | 0.100 |
Why?
|
| Pancreatectomy | 1 | 2017 | 825 | 0.100 |
Why?
|
| Atropine | 1 | 1992 | 244 | 0.100 |
Why?
|
| Hematoma | 1 | 2017 | 768 | 0.100 |
Why?
|
| Pelvis | 1 | 2016 | 738 | 0.100 |
Why?
|
| Aged | 19 | 2017 | 171786 | 0.100 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 906 | 0.100 |
Why?
|
| Efficiency, Organizational | 1 | 2016 | 699 | 0.100 |
Why?
|
| Postoperative Complications | 6 | 2017 | 15889 | 0.100 |
Why?
|
| Markov Chains | 1 | 2015 | 979 | 0.100 |
Why?
|
| Humans | 68 | 2017 | 768970 | 0.100 |
Why?
|
| Mutation | 1 | 2016 | 30266 | 0.090 |
Why?
|
| Workflow | 1 | 2016 | 859 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 755 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 744 | 0.090 |
Why?
|
| Behavior | 1 | 1994 | 543 | 0.090 |
Why?
|
| Heart Valves | 1 | 1993 | 284 | 0.090 |
Why?
|
| Thrombin | 1 | 1993 | 600 | 0.090 |
Why?
|
| Cost Savings | 1 | 2016 | 915 | 0.090 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1992 | 347 | 0.090 |
Why?
|
| Graft Survival | 2 | 2017 | 3888 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2016 | 1337 | 0.090 |
Why?
|
| Heart Block | 1 | 1992 | 390 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2000 | 2055 | 0.090 |
Why?
|
| Thrombophlebitis | 7 | 1992 | 289 | 0.090 |
Why?
|
| Abdomen | 1 | 2016 | 1137 | 0.090 |
Why?
|
| Hospital Costs | 1 | 2016 | 959 | 0.090 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 59739 | 0.090 |
Why?
|
| Endocarditis, Bacterial | 1 | 2014 | 436 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 4 | 2005 | 1601 | 0.080 |
Why?
|
| Thromboembolism | 4 | 2017 | 1004 | 0.080 |
Why?
|
| Health Services Research | 1 | 2016 | 1818 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2016 | 2508 | 0.070 |
Why?
|
| Recombinant Proteins | 6 | 1993 | 6512 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2014 | 1070 | 0.070 |
Why?
|
| Saphenous Vein | 3 | 1990 | 519 | 0.070 |
Why?
|
| Time Factors | 11 | 2017 | 40261 | 0.070 |
Why?
|
| Single-Blind Method | 1 | 2011 | 1586 | 0.070 |
Why?
|
| Electrocardiography | 11 | 2009 | 6413 | 0.070 |
Why?
|
| Prospective Studies | 8 | 2015 | 54962 | 0.070 |
Why?
|
| Heart Failure | 3 | 2011 | 11879 | 0.070 |
Why?
|
| Tissue Donors | 1 | 2017 | 2382 | 0.070 |
Why?
|
| Organ Transplantation | 1 | 2017 | 1178 | 0.070 |
Why?
|
| Boston | 2 | 2017 | 9377 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2884 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 3554 | 0.070 |
Why?
|
| Reoperation | 1 | 2017 | 4342 | 0.070 |
Why?
|
| Circadian Rhythm | 2 | 2001 | 2593 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2784 | 0.060 |
Why?
|
| Wound Healing | 1 | 2017 | 2815 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2016 | 8748 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4926 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5323 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2016 | 41808 | 0.060 |
Why?
|
| Pulmonary Circulation | 6 | 1988 | 744 | 0.060 |
Why?
|
| Survival Rate | 2 | 2015 | 12873 | 0.060 |
Why?
|
| Aspirin | 5 | 1994 | 3135 | 0.060 |
Why?
|
| Dipyridamole | 2 | 1990 | 143 | 0.060 |
Why?
|
| Treatment Outcome | 6 | 2017 | 65480 | 0.060 |
Why?
|
| Cell Movement | 1 | 2016 | 5216 | 0.060 |
Why?
|
| Intracranial Aneurysm | 1 | 2014 | 1293 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2016 | 3335 | 0.060 |
Why?
|
| Female | 16 | 2017 | 397515 | 0.060 |
Why?
|
| Quadriplegia | 1 | 2005 | 227 | 0.060 |
Why?
|
| Periodicity | 1 | 2005 | 348 | 0.060 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2014 | 1568 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2015 | 1550 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 1992 | 1468 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5544 | 0.050 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 1881 | 0.050 |
Why?
|
| Valsalva Maneuver | 1 | 2002 | 99 | 0.050 |
Why?
|
| Angiography | 9 | 1991 | 1598 | 0.050 |
Why?
|
| Heart Conduction System | 2 | 2006 | 1009 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 1376 | 0.050 |
Why?
|
| Risk Factors | 8 | 2017 | 74976 | 0.050 |
Why?
|
| Anticoagulants | 3 | 2016 | 4850 | 0.050 |
Why?
|
| Ventricular Function | 1 | 1983 | 406 | 0.050 |
Why?
|
| Arterial Occlusive Diseases | 2 | 1982 | 746 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 1993 | 5151 | 0.050 |
Why?
|
| Vascular Patency | 3 | 1994 | 917 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10486 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2011 | 2145 | 0.040 |
Why?
|
| Radionuclide Imaging | 9 | 1984 | 1998 | 0.040 |
Why?
|
| Cardiac Output | 4 | 1984 | 838 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11262 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 2002 | 1629 | 0.040 |
Why?
|
| Blood Volume | 2 | 1982 | 546 | 0.040 |
Why?
|
| Calibration | 1 | 2002 | 822 | 0.040 |
Why?
|
| Coronary Angiography | 5 | 1994 | 4541 | 0.040 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 39394 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 1992 | 2034 | 0.040 |
Why?
|
| Chronic Disease | 4 | 2009 | 9384 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2017 | 13055 | 0.040 |
Why?
|
| Graft Occlusion, Vascular | 2 | 1994 | 538 | 0.040 |
Why?
|
| Vascular Resistance | 2 | 2000 | 939 | 0.040 |
Why?
|
| Prognosis | 5 | 2015 | 30046 | 0.040 |
Why?
|
| Adult | 14 | 2017 | 223851 | 0.040 |
Why?
|
| Coronary Circulation | 2 | 1974 | 1617 | 0.030 |
Why?
|
| Pulmonary Artery | 8 | 1988 | 1945 | 0.030 |
Why?
|
| Radiography | 9 | 2005 | 6991 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2017 | 520 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 521 | 0.030 |
Why?
|
| Bilirubin | 1 | 2017 | 438 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 1982 | 1320 | 0.030 |
Why?
|
| Seasons | 1 | 2001 | 1524 | 0.030 |
Why?
|
| Plethysmography, Impedance | 4 | 1983 | 44 | 0.030 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1975 | 311 | 0.030 |
Why?
|
| Hirudin Therapy | 1 | 1993 | 43 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 2 | 2017 | 1737 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2017 | 677 | 0.030 |
Why?
|
| Sex Factors | 2 | 2017 | 10633 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2017 | 81903 | 0.030 |
Why?
|
| Blood Platelets | 1 | 1983 | 2479 | 0.030 |
Why?
|
| Recurrence | 3 | 2005 | 8513 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 1342 | 0.030 |
Why?
|
| Linear Models | 1 | 2002 | 5891 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2017 | 1159 | 0.020 |
Why?
|
| Exercise Test | 1 | 2000 | 2187 | 0.020 |
Why?
|
| Clinical Trials as Topic | 7 | 2006 | 8055 | 0.020 |
Why?
|
| Fibrinogen | 4 | 1988 | 892 | 0.020 |
Why?
|
| Life Tables | 1 | 1991 | 368 | 0.020 |
Why?
|
| Hospitalization | 1 | 2011 | 10847 | 0.020 |
Why?
|
| Young Adult | 2 | 2017 | 60131 | 0.020 |
Why?
|
| Myocardium | 4 | 1980 | 4790 | 0.020 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 1990 | 38 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 20776 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 3438 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13594 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2017 | 1309 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1973 | 610 | 0.020 |
Why?
|
| Pulmonary Heart Disease | 2 | 1984 | 34 | 0.020 |
Why?
|
| Glucagon | 1 | 1972 | 535 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 1992 | 1169 | 0.020 |
Why?
|
| Capillaries | 2 | 1984 | 756 | 0.020 |
Why?
|
| Phlebography | 2 | 1983 | 326 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6131 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 3629 | 0.020 |
Why?
|
| Massachusetts | 1 | 2001 | 8894 | 0.020 |
Why?
|
| Lung | 7 | 1986 | 10099 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14752 | 0.020 |
Why?
|
| Adiposity | 1 | 2017 | 1895 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1996 | 2258 | 0.020 |
Why?
|
| Acute Disease | 5 | 1988 | 7245 | 0.020 |
Why?
|
| Myocardial Infarction | 4 | 1982 | 11521 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 15471 | 0.020 |
Why?
|
| Oxygen | 4 | 1984 | 4272 | 0.020 |
Why?
|
| Microcirculation | 4 | 1986 | 1281 | 0.020 |
Why?
|
| Dogs | 4 | 1980 | 3845 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 1989 | 957 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 1971 | 711 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2017 | 24333 | 0.020 |
Why?
|
| Regression Analysis | 2 | 1992 | 6346 | 0.020 |
Why?
|
| Infusions, Parenteral | 2 | 1982 | 396 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1972 | 1883 | 0.020 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 1987 | 425 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2017 | 9684 | 0.010 |
Why?
|
| Hemorrhage | 4 | 1986 | 3466 | 0.010 |
Why?
|
| Heart Ventricles | 3 | 1984 | 3840 | 0.010 |
Why?
|
| Radiography, Thoracic | 2 | 1984 | 1321 | 0.010 |
Why?
|
| Incidence | 2 | 1993 | 21547 | 0.010 |
Why?
|
| Prevalence | 1 | 2001 | 15879 | 0.010 |
Why?
|
| Health Status | 1 | 2017 | 4095 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1992 | 6236 | 0.010 |
Why?
|
| Filtration | 1 | 1984 | 228 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12095 | 0.010 |
Why?
|
| Random Allocation | 2 | 1988 | 2394 | 0.010 |
Why?
|
| Hypertension | 1 | 2002 | 8617 | 0.010 |
Why?
|
| Heart Rate | 2 | 1986 | 4217 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10592 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13318 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 10400 | 0.010 |
Why?
|
| Double-Blind Method | 4 | 1994 | 12467 | 0.010 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 1977 | 417 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 2006 | 1364 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 1982 | 270 | 0.010 |
Why?
|
| Registries | 1 | 2017 | 8384 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1982 | 642 | 0.010 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1980 | 93 | 0.010 |
Why?
|
| Age Factors | 1 | 2017 | 18435 | 0.010 |
Why?
|
| United States | 2 | 2017 | 73186 | 0.010 |
Why?
|
| Pulmonary Veins | 1 | 1984 | 758 | 0.010 |
Why?
|
| Emergencies | 1 | 1984 | 1221 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2006 | 10115 | 0.010 |
Why?
|
| Coronary Vessels | 2 | 1982 | 3124 | 0.010 |
Why?
|
| Dextrans | 1 | 1979 | 574 | 0.010 |
Why?
|
| Movement | 1 | 1983 | 1490 | 0.010 |
Why?
|
| Plasminogen | 2 | 1973 | 144 | 0.010 |
Why?
|
| Hemoptysis | 1 | 1977 | 152 | 0.010 |
Why?
|
| Pleura | 1 | 1977 | 248 | 0.010 |
Why?
|
| Hydroxychloroquine | 1 | 1979 | 426 | 0.010 |
Why?
|
| Tachycardia | 1 | 1977 | 599 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1974 | 194 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1984 | 1944 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1977 | 345 | 0.010 |
Why?
|
| Snakes | 1 | 1973 | 27 | 0.010 |
Why?
|
| Venoms | 1 | 1973 | 94 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1972 | 305 | 0.010 |
Why?
|
| Microspheres | 1 | 1974 | 789 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1974 | 1500 | 0.010 |
Why?
|
| Mammary Arteries | 1 | 1991 | 82 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1972 | 412 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1972 | 414 | 0.010 |
Why?
|
| Echocardiography | 1 | 1980 | 5047 | 0.000 |
Why?
|
| Heart | 2 | 1986 | 4447 | 0.000 |
Why?
|
| Fibrin | 1 | 1988 | 514 | 0.000 |
Why?
|
| Fibrinolysis | 1 | 1986 | 331 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1992 | 4862 | 0.000 |
Why?
|
| Diagnosis, Differential | 2 | 1977 | 13021 | 0.000 |
Why?
|
| Risk | 1 | 1976 | 9621 | 0.000 |
Why?
|
| Disease Models, Animal | 2 | 1974 | 18354 | 0.000 |
Why?
|
| Intraoperative Care | 1 | 1986 | 771 | 0.000 |
Why?
|
| Myocardial Revascularization | 1 | 1986 | 796 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1991 | 2258 | 0.000 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1986 | 881 | 0.000 |
Why?
|
| Electrodes, Implanted | 1 | 1986 | 841 | 0.000 |
Why?
|
| Pain | 1 | 1977 | 5100 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1986 | 2488 | 0.000 |
Why?
|
| Heart Aneurysm | 1 | 1980 | 114 | 0.000 |
Why?
|
| Papillary Muscles | 1 | 1980 | 192 | 0.000 |
Why?
|
| Clothing | 1 | 1979 | 96 | 0.000 |
Why?
|
| Animals | 4 | 1980 | 169335 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1984 | 15661 | 0.000 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1980 | 477 | 0.000 |
Why?
|
| Joint Prosthesis | 1 | 1979 | 251 | 0.000 |
Why?
|
| Pressure | 1 | 1979 | 1172 | 0.000 |
Why?
|
| Myocardial Contraction | 1 | 1980 | 1526 | 0.000 |
Why?
|
| Leg | 1 | 1979 | 1089 | 0.000 |
Why?
|
| Electric Stimulation Therapy | 1 | 1979 | 637 | 0.000 |
Why?
|
| Clinical Enzyme Tests | 1 | 1973 | 114 | 0.000 |
Why?
|
| Partial Pressure | 1 | 1973 | 248 | 0.000 |
Why?
|
| Neurosurgery | 1 | 1979 | 690 | 0.000 |
Why?
|
| Hip Joint | 1 | 1979 | 1018 | 0.000 |
Why?
|
| Xenon | 1 | 1973 | 120 | 0.000 |
Why?
|
| Radioisotopes | 1 | 1973 | 517 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1973 | 1609 | 0.000 |
Why?
|
| Cough | 1 | 1973 | 598 | 0.000 |
Why?
|
| Cardiomyopathies | 1 | 1980 | 2057 | 0.000 |
Why?
|
| Dyspnea | 1 | 1973 | 1352 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1973 | 1241 | 0.000 |
Why?
|
| Pneumonia | 1 | 1973 | 2164 | 0.000 |
Why?
|